Author
Listed:
- Ewa Terczyńska-Dyla
(Aarhus University)
- Stephanie Bibert
(Infectious Diseases Service, University Hospital and University of Lausanne)
- Francois H. T. Duong
(University of Basel
University Hospital Basel)
- Ilona Krol
(University of Basel
University Hospital Basel)
- Sanne Jørgensen
(Aarhus University)
- Emilie Collinet
(Infectious Diseases Service, University Hospital and University of Lausanne)
- Zoltán Kutalik
(Institute of Social and Preventive Medicine, University Hospital (CHUV) and University of Lausanne
Swiss Institute of Bioinformatics)
- Vincent Aubert
(Service of Immunology and Allergology, University Hospital and University of Lausanne)
- Andreas Cerny
(Fondazione Epatocentro Ticino)
- Laurent Kaiser
(Laboratory of Virology, University Hospitals of Geneva and Medical School, University of Geneva)
- Raffaele Malinverni
(Pourtalès Hospital)
- Alessandra Mangia
(Liver Unit, Scientific Research Institute Casa Sollievo della Sofferenza)
- Darius Moradpour
(University Hospital and University of Lausanne)
- Beat Müllhaupt
(University Hospital of Zurich)
- Francesco Negro
(University Hospitals)
- Rosanna Santoro
(Liver Unit, Scientific Research Institute Casa Sollievo della Sofferenza)
- David Semela
(Canton Hospital)
- Nasser Semmo
(Service of Hepatology, University of Bern)
- Markus H. Heim
(University of Basel
University Hospital Basel)
- Pierre-Yves Bochud
(Infectious Diseases Service, University Hospital and University of Lausanne)
- Rune Hartmann
(Aarhus University)
Abstract
Hepatitis C virus (HCV) infections are the major cause of chronic liver disease, cirrhosis and hepatocellular carcinoma worldwide. Both spontaneous and treatment-induced clearance of HCV depend on genetic variation within the interferon-lambda locus, but until now no clear causal relationship has been established. Here we demonstrate that an amino-acid substitution in the IFNλ4 protein changing a proline at position 70 to a serine (P70S) substantially alters its antiviral activity. Patients harbouring the impaired IFNλ4-S70 variant display lower interferon-stimulated gene (ISG) expression levels, better treatment response rates and better spontaneous clearance rates, compared with patients coding for the fully active IFNλ4-P70 variant. Altogether, these data provide evidence supporting a role for the active IFNλ4 protein as the driver of high hepatic ISG expression as well as the cause of poor HCV clearance.
Suggested Citation
Ewa Terczyńska-Dyla & Stephanie Bibert & Francois H. T. Duong & Ilona Krol & Sanne Jørgensen & Emilie Collinet & Zoltán Kutalik & Vincent Aubert & Andreas Cerny & Laurent Kaiser & Raffaele Malinverni , 2014.
"Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes,"
Nature Communications, Nature, vol. 5(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6699
DOI: 10.1038/ncomms6699
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6699. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.